A61K 49 - Preparations for testing in vivo

Patents for A61K 49 - Preparations for testing in vivo (35,376)
12/2006
12/14/2006	US20060280688 noninvasive imaging in near-infrared (NIR) spectral range for tumor detection with a ligand-conjugated fluorescent probe
12/14/2006	US20060280687 Compounds for tissue imaging and methods of use thereof
12/14/2006	US20060280686 Method of measuring the biological activity of an urotensin II receptor
12/14/2006	US20060280685 Cell-based screen for agents useful for reducing neuronal demyelination or promoting neuronal remyelination
12/14/2006	US20060280684 Using lymphocyte gene expression profiles as diagnostic indicator of asthma, allergic and autoimmune disorders
12/14/2006	US20060280683 Method of identifying inhibitors of GADD45 polypeptide activity, and inhibitors of such activity
12/14/2006	US20060280682 Monitoring two dimensions of diabetes pathogenesis seperately or concurrently (insulin sensitivity and beta-cell sufficiency): uses in diagnosis, prognosis, assessment of disease risk, and drug development
12/14/2006	US20060280681 Food for testing life style-related diseases
12/14/2006	DE3943870B4 Lumineszierend markierte Komponente einer wässrigen Flüssigkeit Luminescent labeled component of an aqueous liquid
12/13/2006	EP1731500A1 5-aminolevulinic acid salt, process for producing the same and use thereof
12/13/2006	EP1731030A1 Method of constructing animal having cancer cells transplanted thereinto
12/13/2006	EP1730190A2 Inhibiting cav3 isoforms and the &25b splice varients for the diagnosis and treatment of cancer
12/13/2006	EP1730169A2 Metal-containing nanolayered composites, and applications thereof
12/13/2006	EP1730077A1 Embolization
12/13/2006	EP1729824A2 Phospholipid analogs for diagnosis and treatment of cancer
12/13/2006	EP1729823A2 Conjugates of angiotensin peptidic analogues and chelating agents for diagnosis and therapy
12/13/2006	EP1729820A2 Perturbed membrane-binding compounds and methods of using the same
12/13/2006	EP1729819A1 X-ray visible drug delivery device
12/13/2006	EP1729818A2 Contrast agents for magnetic resonance imaging
12/13/2006	EP1729750A2 Method for inhibiting tumor formation and growth
12/13/2006	EP1549355B1 Method for the identification of sentinel lymph nodes
12/13/2006	EP1411992B1 Ionic and non-ionic radiographic contrast agents for use in combined x-ray and nuclear magnetic resonance diagnostics
12/13/2006	EP1372737B8 Preparation for the prophylaxis of restenosis
12/13/2006	CN1879065A Magnetically targetable particles comprising magnetic components and biocompatible polymers for site-specific delivery of biologically active agents
12/12/2006	US7148190 Haptotactic peprides
12/12/2006	US7148001 In vitro formation of congophilic maltese-cross amyloid plaques to identify anti-plaque therapeutics for the treatment of Alzheimer's and Prion diseases
12/12/2006	US7147856 Stable radioiodine conjugates and methods of their synthesis
12/12/2006	US7147839 Methods for evaluating tissue morphogenesis and activity
12/12/2006	US7147838 Competitive binding with bombesin; radiopharmaceuticals for treatment of neoplastic diseases
12/12/2006	US7147837 Bioactivated diagnostic imaging constrast agents
12/12/2006	US7147471 Use of moulding compounds for producing treatment devices
12/07/2006	WO2006129080A1 Materials and methods for transducing cells with a viral vector
12/07/2006	WO2006128981A1 Electrostatic patch for allergen screening and applicator for same
12/07/2006	WO2006128735A1 Anti-inflammatory preparations and their intrathecal use in the therapy of inflammatory diseases of the central nervous system
12/07/2006	WO2006112951A3 Method of risk management for patients undergoing natalizumab treatment
12/07/2006	WO2006091861A8 Compositions and methods relating to cns lymphoma
12/07/2006	WO2005112919A8 Self-immolative linkers and drug conjugates
12/07/2006	WO2005112919A2 Self-immolative linkers and drug conjugates
12/07/2006	WO2005048822A3 Antibodies and/or conjugates thereof which bind to the amino terminal fragment of urokinase, compositions and uses thereof
12/07/2006	US20060276628 Pharmaceutical Formulations and Ligands for Use Therein; Mimetics for UEA-1
12/07/2006	US20060275905 Gram positive bacterial mutants and methods of generating and using such mutants
12/07/2006	US20060275833 Methods for the identification of agents that modulate the structure and processing of a membrane bound precursor protein
12/07/2006	US20060275775 Intramolecularly-quenched near infrared fluorescent probes
12/07/2006	US20060275378 Culture media and methods of making and using culture media
12/07/2006	US20060275217 Chemical exchange saturation transfer contrast agents
12/07/2006	US20060275216 Bioactivated diagnostic imaging contrast agents
12/07/2006	US20060275215 Novel imaging agents
12/07/2006	US20060275213 Tumor targeting agents and uses thereof
12/07/2006	CA2609926A1 Electrostatic patch for allergen screening and applicator for same
12/06/2006	EP1728518A1 Method of diagnosing monitoring, staging, imaging and treating gynecologic cancers and testicular cancer
12/06/2006	EP1728423A2 Transgenic animal model of neurodegenerative disorders
12/06/2006	EP1727832A2 Antigen of the pm-2 antibody and use thereof
12/06/2006	EP1727568A2 Method and materials for use in diagnosing viral myocarditis
12/06/2006	EP1221975B1 Polymer stabilized neuropeptides
12/06/2006	EP0837934B1 Human vascular endothelial growth factor 2
12/06/2006	EP0812333B1 Bispecific antibody effective to treat b-cell lymphoma and cell line
12/06/2006	CN1874792A Compounds containing matrix metalloproteinase substrates and methods of their use
12/06/2006	CN1874789A Conjugates for photodynamic therapy
12/06/2006	CN1874719A Semipermeable sensors for detecting analyte
12/06/2006	CN1872348A Ligand of polyoxyethylene of containing target peptide toward to liver cancer
12/06/2006	CN1287859C Magnetic targeted carrier composed of iron and porous materials for targeted delivery of biologically active agents
12/06/2006	CN1287727C In vitro electro-magnetism excitation positioning system for remotely monitoring capsule swallowed in digestive tract
12/05/2006	US7146204 Method and apparatus for quantitatively evaluating a kidney
12/05/2006	CA2218860C Apparatus and method for making gas-filled vesicles of optimal size
12/05/2006	CA2078679C Magnetic metal oxide ultrafine particles-containing composition
11/2006
11/30/2006	WO2006127953A2 Echogenic microbubbles and microemulsions for ultrasound-enhanced nanoparticle-mediated delivery of agents
11/30/2006	WO2006126244A1 Method of producing liposomes containing gas enclosed therein
11/30/2006	WO2006027244A3 Paramagnetic metal polyamino complexes for mri visualization of internalized polynucleotides
11/30/2006	WO2005106367A3 Method and apparatus for accumulating hyperpolarized xenon
11/30/2006	WO2005069935A3 METHODS FOR MEASURING TRANSFORMING GROWTH FACTOR BETA (TGF-β) RECEPTOR SIGNALING ACTIVITY AND USES THEREOF
11/30/2006	US20060272039 Methods of identifying longevity modulators and therapeutic methods of use thereof
11/30/2006	US20060270840 Pentopyranosyl nucleic acid conjugates
11/30/2006	US20060269511 Multilayer binding; lamellar surface structure containing at least two binding compounds is assembled under conditions in which the binding compounds self-regulate in or on the lamellar structure; organized mobile multifunctional conjugate (OMMC) assembly
11/30/2006	US20060269483 SEM cathodoluminescent imaging using up-converting nanophosphors
11/30/2006	US20060269482 Cyclin-dependent kinase inhibition of Rb phosphorylation
11/30/2006	DE10137566B4 Verfahren zur Quantifizierung der Austauschprozesse in den Atemwegen A method for quantifying the exchange processes in the airways
11/30/2006	CA2609373A1 Method of producing liposomes containing gas enclosed therein
11/30/2006	CA2609044A1 Dental composition for detection of carious tissue, detection method
11/29/2006	EP1725268A2 X-ray contrast formulation comprising a mixture of iodinated monomer and dimer
11/29/2006	EP1239886B1 Labelled ascorbic acid derivatives
11/29/2006	CN1871233A Novel chelating agents and chelates and their use
11/29/2006	CN1868546A Model for screening human scavenger donee CD36 antagonist and its application
11/28/2006	US7141659 Starch encapsulation
11/28/2006	US7141541 Use of peptides
11/28/2006	US7141235 System uses a phospholipid in conjunction with a second surfactant of higher water solubility as a stabilizing surfactant to improve gas entrapment
11/28/2006	US7141234 Imaging of drug accumulation as a guide to antitumor therapy
11/28/2006	US7141233 Radionuclide labeling of vitamin B12 and coenzymes thereof
11/28/2006	US7140371 Surface topography method for determining effects of a botulinum toxin upon a muscle and for comparing botulinum toxins
11/23/2006	WO2006125134A1 Peptides whose uptake by cells is controllable
11/23/2006	WO2006124259A1 Effect of substances on sexual function
11/23/2006	WO2006123937A2 Contrast agents
11/23/2006	WO2006123936A2 Contrast agents comprising tungsten- containing cores
11/23/2006	WO2006099037A3 A sporadic tumor mouse model for drug discovery
11/23/2006	WO2006083873A3 Screening and therapeutic methods for treating circadian rhythm disorders
11/23/2006	WO2006073586A3 Radiation dosimetry and blocking antibodies and methods and uses threfor in the treatment of cancer
11/23/2006	WO2006051143A8 Heterocyclic ligands and the gadolinium (iii) complexes thereof with biomedical applications
11/23/2006	WO2006044861A3 Pharmaceutical mixture evaluation
11/23/2006	WO2006020480A3 Adenoviral vector compositions
11/23/2006	WO2005100848A8 Luminaires
11/23/2006	US20060264741 Method and apparatus for imaging abdominal aorta and aortic aneurysms

1 ... 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 ... 354